Ventas, Inc. $VTR Shares Acquired by Assetmark Inc.

Assetmark Inc. lifted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 14.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 93,007 shares of the real estate investment trust’s stock after purchasing an additional 11,541 shares during the quarter. Assetmark Inc.’s holdings in Ventas were worth $6,510,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. NewEdge Advisors LLC increased its position in shares of Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after acquiring an additional 7,097 shares during the last quarter. Empowered Funds LLC boosted its position in shares of Ventas by 6.8% during the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock worth $576,000 after purchasing an additional 536 shares during the period. Woodline Partners LP increased its holdings in Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after purchasing an additional 11,739 shares during the last quarter. Focus Partners Wealth raised its position in Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after purchasing an additional 12,233 shares during the period. Finally, IFP Advisors Inc lifted its stake in Ventas by 61.3% during the second quarter. IFP Advisors Inc now owns 974 shares of the real estate investment trust’s stock worth $62,000 after purchasing an additional 370 shares in the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Royal Bank Of Canada lifted their price objective on Ventas from $83.00 to $91.00 and gave the company an “outperform” rating in a research note on Tuesday, February 10th. UBS Group restated a “neutral” rating and set a $85.00 target price on shares of Ventas in a report on Monday, February 9th. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 price target on shares of Ventas in a research note on Monday, February 9th. Scotiabank increased their price target on shares of Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Finally, Argus set a $88.00 price objective on shares of Ventas in a report on Tuesday, February 10th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average price target of $86.87.

Ventas Stock Down 0.1%

Shares of NYSE VTR opened at $85.15 on Tuesday. The business has a 50-day moving average of $78.63 and a two-hundred day moving average of $74.04. The company has a market capitalization of $40.44 billion, a price-to-earnings ratio of 157.68, a price-to-earnings-growth ratio of 2.11 and a beta of 0.77. Ventas, Inc. has a 1 year low of $60.15 and a 1 year high of $87.20. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67.

Ventas (NYSE:VTR) last issued its earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.Ventas’s revenue was up 21.7% on a year-over-year basis. During the same period last year, the business posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, analysts forecast that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.52 per share. The ex-dividend date is Tuesday, March 31st. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is presently 355.56%.

Insider Activity at Ventas

In related news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This trade represents a 0.92% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the sale, the executive vice president owned 72,755 shares in the company, valued at $6,184,175. This represents a 32.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 88,335 shares of company stock worth $7,109,895. Corporate insiders own 1.00% of the company’s stock.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.